期刊文献+

肺癌雌激素受体表达与三苯氧胺拮抗治疗的研究 被引量:1

A study on the expression of estrogen receptor and the effect of Tamoxifen treatment in lung cancer
下载PDF
导出
摘要 目的 在DNA分子水平上探讨雌激素受体 (ER)表达与肺癌生物学行为的关系及内分泌治疗的价值。方法 用单克隆抗体免疫组化染色 (SP)法检测 4 0例肺癌组织的ER表达 ,分析其临床病理特征和流式细胞仪分析DNA的含量。用逆转录多聚酶链式反应 (RT PCR)测定肺腺癌细胞株LTEP a 2的ER mRNA表达 ,分别在去激素培养条件下观察不同浓度的三苯氧胺 (Tamoxifen ,Tam)和雌二醇 (E2 )对其生长速度、细胞生长周期的影响。结果 肺癌ER阳性率为 5 7 5 %。ER表达与病理类型和组织学分级有关 ,而与肿块直径和临床分期无关。ER阳性者DNA含量低于ER阴性者 (P <0 0 1)。有ER mRNA表达的LTEP a 2肺癌细胞株在去激素环境下 ,低浓度E2 (10 -8M)可促进其生长。高浓度E2 (10 -6M )可抑制细胞生长 ,Tam (10 -6M)可抑制E2 (10 -8M )的生长刺激作用。结论 ER在分化程度较好的肺癌组织 ,特别是非小细胞肺癌中呈高表达趋势。雌激素与肺癌的发生、发展密切相关。 Objective To explore the relationship between the biological behavior of lung cancer and the expression of estrogen receptor in DNA levels and the value of endocrine treatment in lung cancer.Methods Monoclonal antibodies for the immunohistochemical strain assay (sp) of ER were used in 40 specimens of lung cancer.We investigated the clinical appearances of the patients and the pathological features of these samples.Changes in DNA quantity were detected by flow cytometry(FCM).RT PCR was applied in detecting the mRNA of ER in human lung cancer cell strains LTEP a 2.DCC(Dextran treated charcoal)treated fetal bovine serum was used.17β Estradiol and Tamoxifen were added in different concentrations into plates.Cell numbers and cell cycle were studied with cell counting and FCM.Results The positive rate of ER in lung cancer cells were 57 5%.The expression of ER was related to histopathologic grade and the pathological classification of lung cancer cells,but not related to the size of tumor and clinical stages.We found the DNA index of ER(+) lung cancer cells was lower than the ER(-) ones( P< 0 01).LTEP a 2 expressed ER mRNA in estrogen stripped medium,estradiol stimulated the growth of the cell below the concentration of 10 -7 M.Estradiol at the concentration of 10 -6 M could inhibit the growth of the cell.Tamoxifen(10 -6 M) could inhibit the stimulation of Estradiol(10 -8 M).Conclusions ER seems to be more highly expressed in well differentiated lung cancer cells and this trend is more significant in NSCLC.Estrogen is related to the development of lung cancer.Tamoxifen can inhibit the growth of lung cancer cells.
出处 《江苏医药》 CAS CSCD 北大核心 2002年第9期641-643,共3页 Jiangsu Medical Journal
基金 江苏省科委社会发展基金资助项目 (BS973 65 )
关键词 肺癌 雌激素受体 三苯氧胺 雌二醇 治疗 Lung cancer Estrogen receptor Tamoxifen Estradiol
  • 相关文献

参考文献1

  • 1刘叙仪 方红 等.联合异搏定和/或三苯氧胺并化疗治疗81例肺癌疗效[J].中国肿瘤临床,1995,22:44-47.

同被引文献13

  • 1Siegfried JM. Hormone replacement therapy and de- creased lung cancer survival[J]. J Clin Oncol, 2006,24 (1) :9-10.
  • 2Marks JL, Broderick S, Zhou Q, et al. Prognostic and ther- apeutic implications of EGFR and KRAS mutations in re- sected lung adenocarcinoma[J]. J Thorac Oncol, 2008,3 (2) :111-116.
  • 3Henschke CI, Yip R, Miettinen OS. Women's susceptibili- ty to tobacco carcinogens and survival after diagnosis of lung cancer[J]. JAMA, 2006,296(2) : 180-184.
  • 4Kligerman S, White C. Epidemiology of lung cancer in women: risk factors, survival, and screening[J]. AJR Am J Roentgenol,2011,196(2) :287-295.
  • 5Sequist LV, Lynch TJ. EGFR tyrosine kinase inhibitors in lung cancer:an evolving story[J]. Annu Rev Med, 2008, 59(2) :429-442.
  • 6Migliaccio A, Castoria G, Giovannelli P, et al. Cross talk between epidermal growth factor (EGF) receptor and ex- tra nuclear steroid receptors in cell lines[J]. Mol Cell En- docrinol, 2010,327 (1/2) : 19-24.
  • 7Fujimoto N,Wislez M,Zhang J,et al. High expression of ErbB family members and their lig- ands in lung adenoeareinomas that are sensitive to inhibi- tion of epidermal growth factor receptor[J]. Cancer Res, 2005,65 (24) : 11478-11485.
  • 8Paez JG,Janne PA,Lee JC,et al. EGFR mutations in lung cancer:correlation with clinical response to gefitinib ther- apy[J]. Science, 2004,304(5676) : 1497-1500.
  • 9Raso MG, Behrens C, Herynk MH, et al. Immunohisto- chemical expression of estrogen and progesterone recep- tors identifies a subset of NSCLCs and correlates with EGFR mutation[J]. Clin Cancer Res, 2009,15 (17) : 5359- 5368.
  • 10Nose N, Sugio K, Oyama T, et al. Association between es- trogen receptor-beta expression and epidermal growth factor receptor mutation in the postoperative prognosis of adenocarcinoma of the lung [J]. J Clin Oncol, 2009, 27 (3) :411-417.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部